机构：[1]State Key Laboratory for Oncogenes and Related Genes, Division of Gastroenterology and Hepatology, Key Laboratory of Gastroenterology and Hepatology, Ministry of Health, Shanghai Institute of Digestive Disease, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.[2]Laboratory of Tumor Targeted and Immune Therapy, Clinical Research Center for Breast, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University and Collaborative Innovation Center, Chengdu, China.四川大学华西医院[3]Department of Dermatology, University of Texas Southwestern Medical Center, Dallas, TX, USA.[4]Department of Chemistry and Institutes of Biomedical Sciences, Fudan University, Shanghai, China.[5]Department of Gastroenterology, Changsha Central Hospital, Changsha, China.[6]Department of Neurology, Shanghai General Hospital, Shanghai Jiao Tong University, Shanghai, China.[7]Urology Department, The First Affiliated Hospital of Zhejiang University, Zhejiang, China.浙江大学医学院附属第一医院[8]Department of Bioinformatics & Systems Biology, Key Laboratory of Molecular Biophysics of the Ministry of Education, College of Life Science and Technology, Huazhong University of Science and Technology, Wuhan, China.[9]State Key Laboratory for Oncogenes and Related Genes, Division of Gastroenterology and Hepatology, Key Laboratory of Gastroenterology and Hepatology, Ministry of Health, Shanghai Institute of Digestive Disease, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China. jiexu@yahoo.com.
In the version of this Article originally published, 'palmitoyltransferase ZDHHC3 (DHHC3)' was incorrectly referred to as an 'acetyltransferase' rather than an as an 'acyltransferase'; this has now been corrected in five instances. In Fig. 3a, the label for the bottom row of the blots was mistakenly written as 'GAPHD'; it should have read 'GAPDH'. In the two right-most panels of Fig. 4j, the antibody labels 'α-PD-L1' for the reciprocal co-immunoprecipitation of DHHC3 were incorrect; they should have been 'α-DHHC3'. These errors have been corrected in all versions of the Article.
语种：
外文
PubmedID：
中科院(CAS)分区：
出版当年[2019]版：
大类|1 区工程技术
小类|1 区工程：生物医学
最新[2023]版：
大类|1 区医学
小类|1 区工程：生物医学
第一作者：
第一作者机构：[1]State Key Laboratory for Oncogenes and Related Genes, Division of Gastroenterology and Hepatology, Key Laboratory of Gastroenterology and Hepatology, Ministry of Health, Shanghai Institute of Digestive Disease, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
推荐引用方式(GB/T 7714)：
Yao Han,Lan Jiang,Li Chushu,et al.Author Correction: Inhibiting PD-L1 palmitoylation enhances T-cell immune responses against tumours.[J].Nature biomedical engineering.2019,3(5):414.doi:10.1038/s41551-019-0402-7.
APA：
Yao Han,Lan Jiang,Li Chushu,Shi Hubing,Brosseau Jean-Philippe...&Xu Jie.(2019).Author Correction: Inhibiting PD-L1 palmitoylation enhances T-cell immune responses against tumours..Nature biomedical engineering,3,(5)
MLA：
Yao Han,et al."Author Correction: Inhibiting PD-L1 palmitoylation enhances T-cell immune responses against tumours.".Nature biomedical engineering 3..5(2019):414
工程技术